Cargando…

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders

The dopamine transporter (DAT) imaging provides an objective tool for the assessment of dopaminergic function of presynaptic terminals which is valuable for the differential diagnosis of parkinsonian disorders related to a striatal dopaminergic deficiency from movement disorders not related a striat...

Descripción completa

Detalles Bibliográficos
Autores principales:	AKDEMİR, Ümit Özgür, BORA TOKÇAER, Ayşe, ATAY1, Lütfiye Özlem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203173/ https://www.ncbi.nlm.nih.gov/pubmed/33237660 http://dx.doi.org/10.3906/sag-2008-253

Ejemplares similares

Nuclear Medicine Imaging in Pediatric Neurology
por: Akdemir, Ümit Özgür, et al.
Publicado: (2016)

Quantitative and visual analyses of the effect of activity reduction on image metrics and quality in 18F-FDG PET/MRI in pediatric oncology
por: AYDOS, Uğuray, et al.
Publicado: (2022)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
por: Schiebler, Tassilo, et al.
Publicado: (2023)

Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications
por: Ikeda, Ken, et al.
Publicado: (2019)

Relationship Between Metabolic Activity, Cellularity, Histopathological Features of Primary Tumors and Distant Metastatic Potential in Breast Cancer
por: Aydos, Uğuray, et al.
Publicado: (2023)

Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
por: Jakobson Mo, Susanna, et al.
Publicado: (2013)

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
por: Cilia, Roberto, et al.
Publicado: (2011)

Evaluation of brain FDG PET images in temporal lobe epilepsy for lateralization of epileptogenic focus using data mining methods
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2020)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

Dopamine Transporter Imaging Using (99m)Tc-TRODAT-1 SPECT in Parkinson’s Disease
por: Bor-Seng-Shu, Edson, et al.
Publicado: (2014)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Using Artificial Neural Network to Discriminate Parkinson’s Disease from Other Parkinsonisms by Focusing on Putamen of Dopamine Transporter SPECT Images
por: Chien, Chung-Yao, et al.
Publicado: (2020)

Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
por: Nazari, Mahmood, et al.
Publicado: (2021)

The utility of the combination of a SPECT study with [(123)I]-FP-CIT of dopamine transporters and [(123)I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
por: Uyama, Naoto, et al.
Publicado: (2017)

Utility of susceptibility-weighted imaging in Parkinson’s disease and atypical Parkinsonian disorders
por: Wang, Zhibin, et al.
Publicado: (2016)

The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
por: Suwijn, Sven R, et al.
Publicado: (2015)

Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome
por: Warhadpande, Devdutta S., et al.
Publicado: (2022)

Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
por: Potashkin, Judith A., et al.
Publicado: (2012)

Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes
por: Zlotnik, Yair, et al.
Publicado: (2015)

Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT
por: Pitkonen, Miia, et al.
Publicado: (2012)

Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes
por: Vlaar, Annemarie MM, et al.
Publicado: (2007)

Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes
por: Shin, Dong Hoon, et al.
Publicado: (2006)

TSPO imaging in parkinsonian disorders
por: Gerhard, Alexander
Publicado: (2016)

SPECT Molecular Imaging in Parkinson's Disease
por: Wang, Ling, et al.
Publicado: (2012)

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
por: Meles, Sanne K., et al.
Publicado: (2017)

Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

Consolidation of a Learned Skill Correlates with Dopamine SPECT Uptake in Early Parkinson's Disease
por: Nicastro, Nicolas, et al.
Publicado: (2018)

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020)

Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts
por: Saeed, Usman, et al.
Publicado: (2017)

Effects of different percentages of body weight-supported treadmill training in Parkinson's disease: a double-blind randomized controlled trial
por: ATAN, Tuğba, et al.
Publicado: (2019)

Dopamine Transporter maging with Tc-99m TRODAT-1 SPECT in Parkinson’s isease and its orrelation with linical isease everity
por: Patel, Asra, et al.
Publicado: (2019)

Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake
por: Bae, Yun Jung, et al.
Publicado: (2023)

Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism
por: Honkanen, Emma A., et al.
Publicado: (2019)

Comparison of perfusion (18)F-FP-CIT PET and (99m)Tc-ECD SPECT in parkinsonian disorders
por: Chun, KyungAh, et al.
Publicado: (2021)

Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder
por: Cao, Ruihua, et al.
Publicado: (2020)

Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
por: Heng, Nicholas, et al.
Publicado: (2023)

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
por: Hall, Sara, et al.
Publicado: (2018)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_vjmughk509pvmobc9iqfrhqd3b